LBRX · Nasdaq · SIC 2834: Pharmaceutical Preparations
13
SEC Filings
Business Summary
License and Other AgreementsRoyalty Agreements. As of December 31, 2025, certain of our former and current officers and their affiliates held 1.13% of the future royalties. Components of Results of Operations Revenue To date, we have not recognized any revenues, including revenues from product sales. We do not expect to generate any revenue from the sale of products in the foreseeable future. If our development efforts for LB-102 or any future product candidates are successful and result in regu...